Levothyroxine Sodium
Levothyroxine Sodium
NADAC/unit
N/A
No Shortage
11 Manufacturers
84 ANDAs
Active Shortages
2025-07-10 Discontinuation of the manufacture of the drug, EMD Serono, Inc.
2025-07-10 Discontinuation of the manufacture of the drug, EMD Serono, Inc.
2025-07-10 Discontinuation of the manufacture of the drug, EMD Serono, Inc.
2025-07-10 Discontinuation of the manufacture of the drug, EMD Serono, Inc.
2025-07-10 Discontinuation of the manufacture of the drug, EMD Serono, Inc.
Market Intelligence
2026-01-21 Class II Recall: Alvogen, Inc
2025-10-15 Class II Recall: ACCORD HEALTHCARE, INC.
2025-08-20 Class II Recall: Pfizer
2025-07-23 Class II Recall: ACCORD HEALTHCARE, INC.
2025-07-23 Class II Recall: ACCORD HEALTHCARE, INC.
Generic Manufacturers
ABBVIE INCACCORD HEALTHCARE INCALVOGEN INCASCENT PHARMACEUTICALS INCCEDIPROF INCEMD SERONO INCFRESENIUS KABI USA LLCGENUS LIFE SCIENCES INCHIKMA PHARMACEUTICALS USA INCIBSA INSTITUT BIOCHIMIQUE SAJEROME STEVENS PHARMACEUTICALS INCKING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLCLUPIN INCMACLEODS PHARMACEUTICALS LTDMAIA PHARMACEUTICALS INCMYLAN PHARMACEUTICALS INCONESOURCE SPECIALTY PTE LTDPIRAMAL CRITICAL CARE LTDWATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCXIROMED PHARMA ESPANA SLZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.